Start Date
September 1, 2019
Primary Completion Date
September 1, 2020
Study Completion Date
November 1, 2020
LiverFASt
LiverFASt™ is a blood based diagnostic test utilizing a patented algorithm to determine presence and the progression of liver disease. The test is non-invasive, simple, and less expensive than liver biopsy or liver imaging.
ObvioHealth, Orlando
Lead Sponsor
OBVIO HEALTH USA, Inc.
UNKNOWN
Fibronostics USA, Inc
OTHER